Revance Therapeutics Statistics
Total Valuation
RVNC has a market cap or net worth of $342.87 million. The enterprise value is $566.84 million.
| Market Cap | 342.87M |
| Enterprise Value | 566.84M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RVNC has 104.22 million shares outstanding. The number of shares has increased by 16.35% in one year.
| Shares Outstanding | 104.22M |
| Shares Change (YoY) | +16.35% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 8.47% |
| Owned by Institutions (%) | 76.18% |
| Float | 70.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.47 |
| Forward PS | 1.20 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.80
| Current Ratio | 3.80 |
| Quick Ratio | 3.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -60.10% |
| Return on Capital (ROIC) | -96.92% |
| Revenue Per Employee | $392,027 |
| Profits Per Employee | -$542,690 |
| Employee Count | 597 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.33 |
Taxes
In the past 12 months, RVNC has paid $300,000 in taxes.
| Income Tax | 300,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.60% in the last 52 weeks. The beta is 1.09, so RVNC's price volatility has been similar to the market average.
| Beta (1Y) | 1.09 |
| 52-Week Price Change | -89.60% |
| 50-Day Moving Average | 5.04 |
| 200-Day Moving Average | 10.10 |
| Relative Strength Index (RSI) | 23.70 |
| Average Volume (30 Days) | 1,800,248 |
Short Selling Information
The latest short interest is 11.63 million, so 11.15% of the outstanding shares have been sold short.
| Short Interest | 11.63M |
| Short Previous Month | 13.55M |
| Short % of Shares Out | 11.15% |
| Short % of Float | 16.44% |
| Short Ratio (days to cover) | 5.89 |
Income Statement
In the last 12 months, RVNC had revenue of $234.04 million and -$323.99 million in losses. Loss per share was -$3.83.
| Revenue | 234.04M |
| Gross Profit | 159.68M |
| Operating Income | -316.78M |
| Pretax Income | -323.69M |
| Net Income | -323.99M |
| EBITDA | -290.64M |
| EBIT | -304.33M |
| Loss Per Share | -$3.83 |
Balance Sheet
The company has $254.47 million in cash and $478.43 million in debt, giving a net cash position of -$223.97 million or -$2.15 per share.
| Cash & Cash Equivalents | 254.47M |
| Total Debt | 478.43M |
| Net Cash | -223.97M |
| Net Cash Per Share | -$2.15 |
| Equity / Book Value | -151.60M |
| Book Value Per Share | -1.45 |
| Working Capital | 249.64M |
Cash Flow
In the last 12 months, operating cash flow was -$216.58 million and capital expenditures -$6.89 million, giving a free cash flow of -$223.46 million.
| Operating Cash Flow | -216.58M |
| Capital Expenditures | -6.89M |
| Free Cash Flow | -223.46M |
| FCF Per Share | -$2.64 |
Margins
Gross margin is 68.23%, with operating and profit margins of -135.35% and -138.43%.
| Gross Margin | 68.23% |
| Operating Margin | -135.35% |
| Pretax Margin | -138.30% |
| Profit Margin | -138.43% |
| EBITDA Margin | -124.18% |
| EBIT Margin | -130.03% |
| FCF Margin | -95.48% |
Dividends & Yields
RVNC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.35% |
| Shareholder Yield | -16.35% |
| Earnings Yield | -94.49% |
| FCF Yield | -65.17% |
Analyst Forecast
The average price target for RVNC is $14.00, which is 325.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 325.53% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 31.26% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RVNC has an Altman Z-Score of -6.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.74 |
| Piotroski F-Score | 3 |